Dec 31 (Reuters) -
ANBIO BIOTECHNOLOGY FILES FOR US IPO OF UP TO 1.6 MILLION CLASS A ORDINARY SHARES - SEC FILING
ANBIO BIOTECHNOLOGY - IPO PRICE EXPECTED BETWEEN $5.00 AND $6.00 PER SHARE
ANBIO BIOTECHNOLOGY - TO LIST CLASS A SHARES ON NASDAQ UNDER SYMBOL 'NNNN'
ANBIO BIOTECHNOLOGY: AC SUNSHINE SECURITIES LLC. IS ACTING AS UNDERWRITER TO THE U.S. IPO
Source text: [ID:n0001213900-24-114129]
Further company coverage: [ ]
((Reuters.Briefs@thomsonreuters.com;))